American International Group, Inc. Ovid Therapeutics Inc. Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.72 - $4.04 $688 - $1,022	-253 Reduced 0.85%	29,386 $89,000
Q4 2023 Feb 13, 2024	SELL	$2.98 - $3.78 $357 - $453	-120 Reduced 0.4%	29,639 $95,000
Q3 2023 Nov 13, 2023	BUY	$3.23 - $3.97 $3,417 - $4,200	1,058 Added 3.69%	29,759 $114,000
Q2 2023 Aug 04, 2023	BUY	$2.53 - $3.89 $72,613 - $111,646	28,701 New	28,701 $94,000
Q2 2021 Aug 13, 2021	SELL	$3.3 - $4.49 $91,505 - $124,503	-27,729 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$2.42 - $4.47 $179 - $330	74 Added 0.27%	27,729 $111,000
Q4 2020 Feb 12, 2021	BUY	$2.28 - $6.84 $4,685 - $14,056	2,055 Added 8.03%	27,655 $64,000
Q3 2020 Nov 04, 2020	SELL	$5.39 - $8.24 $3,142 - $4,803	-583 Reduced 2.23%	25,600 $147,000
Q2 2020 Aug 12, 2020	BUY	$2.67 - $7.91 $69,908 - $207,107	26,183 New	26,183 $193,000
Q2 2019 Aug 13, 2019	SELL	$1.59 - $2.14 $13,357 - $17,978	-8,401 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$1.77 - $3.56 $483 - $971	-273 Reduced 3.15%	8,401 $15,000
Q4 2018 Feb 13, 2019	SELL	$2.42 - $6.6 $162 - $442	-67 Reduced 0.77%	8,674 $21,000
Q3 2018 Nov 09, 2018	BUY	$5.6 - $11.0 $884 - $1,738	158 Added 1.84%	8,741 $50,000
Q2 2018 Aug 08, 2018	BUY	$6.16 - $10.14 $4,576 - $7,534	743 Added 9.48%	8,583 $67,000
Q1 2018 May 07, 2018	BUY	$6.53 - $9.82 $28,973 - $43,571	4,437 Added 130.38%	7,840 $55,000
Q4 2017 Feb 09, 2018	BUY	$6.12 - $12.31 $104 - $209	17 Added 0.5%	3,403 $34,000
Q3 2017 Nov 09, 2017	BUY	$5.32 - $9.77 $18,013 - $33,081	3,386	3,386 $29,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.